The Role of HIV Infection, Cognition, and Depression in Risky Decision-Making
Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
Abstract
The authors examined the impact of HIV, cognitive dysfunction, and depression on decision-making. HIV+ (N=100) and HIV− (N=26) participants were administered a comprehensive neuropsychological battery, a modified version of the Iowa Gambling Task, and a measure of depressive symptoms. HIV+ participants demonstrated more difficulties in learning the gambling task than did HIV− participants. Executive functioning and depression emerged as strong predictors of gambling task performance. Depression partially mediated the relationship between executive functioning and gambling performance. Our findings suggest that HIV infection, executive dysfunction, and depression place individuals at risk for poor decision-making.
Decision-making involves collecting information about the expected valences, alternatives, and probabilities of available response options. Disruption to any of these component processes may result in risky behavior. The neurobiological circuitry underlying social decision-making includes such areas as the ventromedial prefrontal cortex (vmPFC) and insular cortex.1 Patients with disruptions to the ventromedial cortex more frequently demonstrate impairments in social decision-making, in spite of otherwise largely-preserved intellectual abilities.2,3 Tasks that measure social decision-making (i.e., weighing of risk and benefits) have demonstrated both selectivity and sensitivity to ventromedial-prefrontal cortex lesions. Poor performance on decision-making can persist despite relatively unimpaired performance on tasks of planning and problem-solving that reflect dorsal-lateral prefrontal functioning (e.g., the Wisconsin Card-Sorting test), suggesting different neuroanatomical circuitry that subsumes these related, yet dissociable, processes. One such instrument, the Iowa Gambling Task (IGT), was developed in order to investigate the decision-making strategies in individuals with frontal lobe lesions. The task includes four decks of cards from which to choose, with each selected card resulting in either winning or losing a sum of “replica” money. Two out of the four decks will result in a net profit by the end of the task (i.e., Safe decks), whereas card selection from the other two will ultimately result in a loss (i.e., Risky decks). The decks that result in the net loss, however, offer larger payoffs early in the task than the others. Through its design, this task assesses participants’ capacity for decision-making and risk-taking by tracking which decks they draw from, thereby measuring their responses to reward/punishment and concern for future outcomes.
Decision-Making Among HIV+ Adults
The pattern of neuropsychological deficits typically observed in HIV+ individuals is consistent with frontal-striatal dysfunction (i.e., difficulties with attention and concentration, information-processing speed, motor functioning, and executive functioning).4 There is also evidence that poor decision-making is prevalent among this population.5,6 Where HIV can result in problems with decision-making, individuals who contract HIV tend to engage in greater risk-taking practices in general, which makes this population ideal for studying decision-making performance.7 Hardy and colleagues5 administered a modified version of the IGT to a group of HIV+ patients and seronegative control subjects. HIV+ patients performed worse on the gambling task than controls. Similarly, among substance-dependent HIV+ individuals, deficits have also been observed in decision-making.6,8 Decision-making performance on the IGT moderated the relationship between emotional distress and reported sexual risk among HIV+ individuals, such that better performance on the IGT and greater distress predicted greater sexual risk-taking.9 However, among individuals with worse IGT performance, there was no significant relationship between distress and reported sexual risk, suggesting that emotional distress in isolation does not play a critical role in poor IGT performance. In other words, intact neural circuitry subserving decision-making is critical in order for emotional distress to have an influence on the functioning of this neural circuitry, thereby increasing risk-taking behavior. Overall, results support the contention that HIV+ individuals are at risk for poor decision-making behavior.
Depression, Cognition, and Decision-Making
Depression is considered to be one of the neuropsychiatric features associated with HIV.10,11 Although a number of studies have linked depression to impairments in executive functioning, attention, memory, and psychomotor speed,12 such associations are not consistent, and many studies have failed to find direct associations between symptoms of depression and cognitive dysfunction.13–15 Inconsistencies across studies may be due to methodological differences in how depression is diagnosed, measured, reported, or handled, with regard to severity.16
Nevertheless, what is consistent, and of particular interest to the current study, are findings supporting dysfunction in decision-making in depressed patients.17 For instance, among depressed adolescents, Han and colleagues found impairments in both non-emotional areas of cognitive functioning (sustained attention and conflict-processing) as well as emotionally-laden domains (affective decision-making), with the latter being more associated with current mood state.18 Furthermore, deficits in emotionally-charged decision-making tasks have also been observed in chronic pain patients with depression. There is considerable evidence that depression leads to biases in processing emotional information that can result in poorer performance on an affective Go/No-Go task.19,20
It is thought that depressed individuals are less likely to respond to negative feedback from the environment because of an decreased sensitivity to punishment,21–24 difficulties in recognizing rewards,22 or an inability to maintain reinforced behavior.25,26 This, in turn, can result in poor performance on decision-making or learning tasks, particularly when the outcome is unclear or misleading.27 Depressed patients may have difficulty with flexible decisions-making requiring them to change their response choices when a previously disadvantageous choice becomes advantageous, and vice versa.17,28 Together, these studies suggest that depression may adversely affect social decision-making despite relatively intact cognition.
The extent to which cognition affects decision-making is only a small component of understanding the underlying processes involved in decision-making. Other variables linked to both cognition and decision-making may explain the process by which cognition actually influences decision-making. A variable may be termed a mediator “to the extent that it accounts for the relation[ship] between the predictor and the criterion.”29 Although cognition and depression have been linked to poor decision-making, it is unclear whether mild disturbances in cognition (such as those typically reported by HIV+ patients) affects poor decision-making, or other variables, such as depression, modulate the relationship between the two constructs.
The purpose of the current investigation was to examine decision-making performance among HIV+ and HIV– individuals and to determine which cognitive and psychiatric features, if any, are associated with decision-making. It was expected that HIV+ individuals would demonstrate more poor decision-making choices than HIV– individuals. It was also expected that gambling task performance would be correlated with executive dysfunction and depressed mood. Finally, we expected depression to partially mediate the relationship between cognition and decision-making (as assessed by gambling performance).
Method
Participants
Before data collection, all study procedures were approved by UCLA Institutional Review Board. Participants consisted of 126 HIV+ (N=100) and HIV− (N=26) individuals, who were recruited from various community clinics in the Los Angeles area. Exclusionary criteria included history of neurological disorder (e.g., head injury with loss of consciousness in excess of 60 minutes, stroke or seizure disorder, and CNS opportunistic infections). All participants were required to demonstrate at least a 6th-grade reading level and provide written informed consent. (See Table 1 for sample demographics.)
| Variable | HIV+ (N=100) | HIV− (N=26) |
|---|---|---|
| Age, years | 43.83 (7.30) | 46.31 (13.21) |
| Gender, % men | 76.4 | 50 |
| Ethnicity, % | ||
| African American | 68.8 | 43.1 |
| Caucasian | 17.3 | 44.8 |
| Hispanic | 9.1 | 8.6 |
| Multiracial | 0 | 1.7 |
| American Indian | 1.0 | 1.7 |
| Asian American | 1.4 | 0 |
| Education | 13.08 (2.3) | 14.16 (2.13) |
| CD4 count | 361.50 (248.32) | N/A |
| Undetectable viral load, % | 33 | N/A |
| *Premorbid IQ | 103.01 (10.41) | 111.30 (10.58) |
| *% Past substance use | 61 | 31 |
| Attention/working memory, T-score | 42.56 (7.39) | 48.05 (8.33) |
| Speed of information-processing | 40.64 (9.52) | 44.48 (9.69) |
| Learning and memory, T-score | 38.02 (12.06) | 44.83 (11.34) |
| Verbal function, T-score | 45.57 (11.75) | 46.95 (11.29) |
| Motor function, T-score | 37.96 (10.85) | 40.27 (10.48) |
| Executive function, T-score | 41.51 (7.97) | 46.24 (8.55) |
| Global functioning, T-score | 41.08 (6.85) | 45.11 (6.39) |
| *Depression score | 14.53 (10.93) | 8.36 (10.39) |
| *Gambling Index score | 5.37 (18.84) | 21.29 (23.80) |
Values are mean (standard deviation), unless otherwise indicated.
*
p<0.05.
Neuropsychological Assessment
All participants were administered a comprehensive neuropsychological battery. Raw scores were converted to demographically-corrected T-scores (Table 2), which were then combined to create domain scores for the areas of attention and working memory, information-processing speed, learning and memory, motor, and executive function, by use of validated approaches.4
| Cognitive Domain | Normative Data |
|---|---|
| Speed of information-processing | |
| Symbol Digit Modalities Test | Smith et al., 198245 |
| Trail-Making Test Part A | Heaton et al., 199146 |
| Learning and memory | |
| CVLT Trials 1–5 | Delis et al., 198747 |
| CVLT short-delay free recall | Delis et al., 198747 |
| CVLT long-delay free recall | Delis et al., 198747 |
| Verbal fluency | |
| Controlled Oral Word-Association Test | Heaton et al., 199146 |
| Attention and working memory | |
| Paced Serial Addition Test | Stuss et al., 198848 |
| Executive functioning | |
| Short Category Test, booklet format | Wetzel and Boll, 198749 |
| Trail-Making Test Part B | Heaton et al., 199146 |
| Stroop Color–Word Test–Interference | Heaton et al., 199146 |
| Motor functioning | |
| Grooved Pegboard, dominant hand | Heaton et al., 199146 |
| Grooved Pegboard, nondominant hand | Heaton et al., 199146 |
CVLT: California Verbal Learning Test.
Gambling Task
The gambling task used in the present study is modeled from that of Bechara and colleagues.30 Participants are told that 1) the goal of the task is to maximize profit on the loan of play money; and 2) they are free to switch decks whenever and as often as they desire. They are not told how many cards they are allowed to select (the game is over after 100 cards are selected). The ultimate yield is smaller for the higher-paying decks, A and B, because of larger penalties. The ultimate yield is larger for the lower-paying decks, C and D, because of the smaller penalties. Thus, participants must discriminate between short-term and long-term consequences. The Gambling Task has been used in a variety of populations, including the HIV population5,8 and has demonstrated convergent validity with attention and executive functions31 and ecological validity among drug-abusers.32 To examine whether participants were able to learn to discriminate between short-term and long-term consequences, a learning index was created by subtracting the average number of advantageous cards (i.e., decks A and B) selected from the first two blocks of 20 cards from the average of advantageous cards for the last three blocks. The learning-index approach is based on the idea that subjects’ performance on the latter trials of the gambling task should reflect a more systematic approach to card-selection than earlier trials. Given this, it is expected that as participants adjust to the task (first two blocks of 20 cards), card selection occurs in a haphazard, less systematic fashion. Conversely, for subjects with intact decision-making ability, selection over the last three blocks will demonstrate a more systematic approach, which reflects learning. In other words, as the task progresses and participants are exposed to rewards and losses, they will become better able to anticipate risky versus safe choices. Hence, it is expected that the last three blocks should show increases in the number of advantageous cards selected. The learning index represents the “net” amount of learning that takes place over the course of the task.
Depression
Depressive symptoms were measured with the Beck Depression Inventory–II (BDI–II).33 The BDI–II is a 21-item, self-report rating scale that asks about the presence and prominence of cognitive, affective, and somatic symptoms of depression over the past week. Scores on each item can range from 0 (symptom absent) to 3 (presence of symptom is pronounced), yielding a possible range of BDI Total scores of 0 to 63. Total BDI–II score was used for statistical analyses. Given the overlap between somatic complaints reported as a function of HIV illness and somatic items on the BDI–II, we split BDI–II items into three factors: mood/motivation disturbance, self-reproach, and somatic disturbance, by use of procedures described by Castellon and colleagues.34
Research Design and Statistics
This is a contrasted-groups study that used multiple regression and nonparametric statistics (Mann-Whitney U) to examine differences between HIV+ and HIV– participants on premorbid intellectual functioning (IQ), neuropsychological performance (NP), depression, and gambling performance. First, we examined the contributions of confounding variables to our study findings. Given that HIV+ and HIV– participants significantly differed on premorbid IQ (U=668.50; p<0.0001), multiple regression was conducted to determine whether HIV status continued to predict the variation in neuropsychological performance, depression, and gambling performance beyond that of premorbid intellectual ability. There was also a disproportionately higher number of African Americans in our sample of HIV+ participants (χ2[5]=21.47; N=126; p<0.001). Therefore, we examined ethnic differences between African Americans and other ethnic groups in neuropsychological test performance and IGT performance by use of analysis of variance (ANOVA). Next, two-tailed, bivariate Pearson correlations were used to examine relationships between NP, depression, and gambling performance for both status groups. Finally, multiple linear-regression analysis was conducted with our HIV+ patients to examine predictors of gambling performance. Before running multiple-regression analyses, all variables were inspected to ensure that statistical assumptions were met. For multiple regression, executive functioning was entered into the first step (as executive functioning demonstrated the strongest relationship to gambling performance), and depression in the second step. We examined the significance of R2 change and corresponding β weights to determine whether depression mediated the relationship between cognition and gambling performance. In order to correct for multiple comparisons, the false-discovery rate (FDR) approach was used to correct for multiple comparisons made in primary study analyses.35 Instead of controlling for the chance of any false positives (e.g., the Bonferroni method), FDR controls for the expected proportion of false-positives within a total number of comparisons.
Results
HIV Status, Neuropsychiatric Performance, and Gambling Performance
There were no significant differences between drug-history groups (past use versus no use) on neuropsychological functioning and gambling performance. After controlling for premorbid IQ, HIV status did not significantly contribute to the variation in neuropsychological performance, (Δ r2 =0.004; p=0.201). However, HIV status continued to predict the variance in gambling performance after controlling for premorbid IQ (Δ r2=0.043; p=0.01), suggesting that participants’ HIV status contributes to performance on the gambling task. Analysis of group differences revealed that HIV+ participants demonstrated more difficulty with learning on the gambling task than HIV− participants (U=758.0; p=0.002; Table 1 and Figure 1). As stated previously, given the disproportionate number of African Americans in the HIV+ group, we examined ethnic differences on neuropsychological performance and gambling performance. We found ethnic differences in global neuropsychological performance (F[5,120]=5.233; p<0.001. Post-hoc analyses demonstrated that African Americans performed significantly worse than Caucasians (least significant difference [LSD] = −5.013; p<0.001). However, there were no significant ethnic differences in IGT performance (F[5,120]=1.33; NS). Analysis of covariance (ANCOVA) revealed that ethnic differences in neuropsychological performance no longer remained significant after controlling for premorbid IQ (F[(5,119]=0.773; NS).
FIGURE 1. Performance on Gambling Task of HIV-Status Groups
Number of advantageous cards was computed by subtracting the number of risky cards selected from the number of safe cards.
For the entire sample, gambling learning index score was positively associated with attention and working memory (r[125]=0.18; p=0.05) and executive functioning (r[125]=0.25; p<0.001).
HIV Status, Depression, and Gambling Performance
HIV+ patients endorsed more symptoms of depression than did HIV− patients (F[1, 125]=14.70; p<0.001). HIV+ participants demonstrated significantly higher scores on mood/motivation disturbance (U=4,629.0; p<0.0001), self-reproach (U=3,801.0; p<0.0001), and somatic disturbances (U=3,231.0; p<0.0001) than HIV− participants. Given that HIV+ participants demonstrated significantly higher scores on each dimension of the BDI–II, the total BDI–II score was used in subsequent analyses. Depression was negatively associated with gambling learning-index score (r[125] = −0.27; p<0.001). Analysis of depression symptoms and gambling performance revealed that whereas both groups demonstrated similar effect sizes (HIV+: r[100] = −0.23; p=0.02); HIV−: r[26] = −0.20; NS), the relationship was only statistically significant for HIV+ patients. Evaluation of effect sizes for both groups indicates that depression affects gambling performance.
Predictors of Gambling Performance Among HIV+ Patients
Executive functioning held the strongest relationship with gambling performance (r2=0.062; p<0.001; β=0.250) and was also predictive of depressive symptoms (β = −0.124). Therefore, executive functioning was used in the partial mediation model, with depression and gambling performance. Depression predicted gambling performance after controlling for executive functioning (r2=0.110; p<0.001; β = −0.226). Inspection of standardized β weights associated with both direct and indirect effects of executive functioning on gambling performance revealed that depression partially mediated the relationship between executive functioning and gambling performance (β=0.126). Figure 2 depicts the mediation model.
FIGURE 2. Mediation Model (using standardized β coefficients)
The number of advantageous cards was computed by subtracting the number of risky cards selected from the number of safe cards.
Discussion
This study compared the impact of depression and cognition on decision-making in a cohort of HIV+ and HIV− adults. Using a learning index, we examined how various factors, such as HIV status, cognition, and depression, interfered with participants’ ability to learn on a decision-making task. Findings from this study extend the current literature by demonstrating the role of depression symptoms in decision-making and how emotional distress may result in problems in learning from rewards and punishments in spite of intact cognition. Consistent with findings in other studies,5,8,36 HIV+ individuals demonstrated poorer neuropsychological functioning, including decision-making (assessed by a modified version of the Iowa Gambling Task), as compared with seronegative individuals.
Decision-making was associated with attention and executive functioning for the entire sample, which is consistent with several previous studies,5,6 although not all.8,37 Further analysis into the relationship between discrete cognitive functions and gambling task performance demonstrated that executive functioning was most strongly associated with gambling performance, which is not particularly surprising, given that successful performance on the gambling task requires processes (i.e., flexible appraisals of the affective significance of stimuli, learning, and problem-solving) that are largely subserved by frontostriatal functions.
HIV+ individuals demonstrated higher levels of depression symptoms, which is consistent with other studies examining rates of depression among HIV+ and HIV– individuals.11 Depression symptoms were strongly related to gambling-task performance, which is also consistent with Damasio’s somatic marker hypothesis, which asserts that emotional processes (anticipatory affective signals/somatic states) can guide or bias decision-making,38 and with previous studies that have demonstrated that depressed individuals have decreased response to negative feedback.23 In addition to decreased sensitivity, allocation of cognitive resources becomes reduced, which results in deficits in remembering and engaging in other effortful cognitive processes.39 Thus, deficits become more evident in effortful tasks, rather than tasks that involve automatic processes, which may partially explain inconsistent findings related to depression and cognition.
Successful performance on the gambling task requires the generation of autonomic responses, signaling emotional identification of choices made and the rewards and penalties received as a consequence of choices.3 Moreover, there is increasing evidence suggesting that depressed individuals appear biased in favor of high-risk/high-reward options.40,41 Depression, in itself, involves poor flexibility in shifting behavior when reward conditions change, which supports the hypothesis that depression could involve a rigid, generalized strategy for responding to reward, regardless of changes in contingencies, and with models emphasizing that decreases in positive affect are a fundamental characteristic of depression and lack of response to rewards.42
It has been suggested that the gambling task measures different types of decisions. More specifically, there may be a differential influence of affective processes and executive functions, depending on whether decisions are made under ambiguity (e.g., first trials of the gambling task) or under risk (e.g., latter trials of task).43,44 In the current investigation, learning differences due to HIV status, cognitive impairment, or depression symptoms did not emerge until the latter trials of the task, which is when participants are expected to distinguish between risky versus safe decks. It is of particular interest that depression partially mediated the relationship between decision-making and executive functioning, demonstrating the importance of depression symptoms to decision-making processes. Our partial mediation model supports the contention that that emotional distress, even at a subclinical level, may be associated with risk-taking among those with intact executive functioning.9 Furthermore, our results demonstrate that affective disturbance has profound effects on decision-making. Engaging in risk-behaviors or decreases in sound judgment may be an early sign of depression. Practitioners working with HIV-infected individuals should to be sensitive to declines in judgment because these can signal depression, which can be aggressively treated through pharmacotherapy, evidenced-based psychotherapy, or a combination of the two methods.
We recognize that the current study design is limited with regard to addressing the “chicken/egg” problem; that is, whether depression associated with HIV status causes decision-making impairments on the gambling task, or whether individuals with HIV evidence premorbid difficulties with decision-making, which placed them at risk for infection and subsequent depressed mood. Our HIV+ participants were more likely to report past substance abuse, which suggests that this population may be more prone to engaging in risky behaviors in general. Furthermore, we were unable to target individuals with syndromic levels of depression (such as those diagnosed with Major Depressive Disorder), as most of our participants’ BDI–II scores ranged from mild to moderate classifications of severity. Therefore, it is possible that relationships between executive dysfunction and depression may be, in part, influenced by mood severity. Moreover, alterations in reward choice and behavior may play a role in the continuity of depressive symptoms and, consequently, poor decision-making. Studies using a longitudinal investigation with a sample of individuals with clinically diagnosed major depression would be ideal to address this issue.
Although it could be argued that the observed relationships between cognition, depression, and decision-making are solely generalizable to the HIV+ population (because of the lack of significant findings in the HIV− population), we believe that the moderate effect sizes observed support their importance in decision-making for both subgroups. Although the relationships between these variables failed to reach statistical significance for the HIV− subgroup, this was largely due, in part, to small sample size (N=26). We recognize that a larger sample of controls would have been ideal, and that this is indeed a limitation to the current study. Nevertheless, despite this limitation, our findings are in accordance with the extant literature that has demonstrated that relationships between cognitive dysfunction and depressed mood affect performance on effortful cognitive tasks, and the findings extend previous work by demonstrating how dysphoric mood plays a partially mediating role in cognition and decision-making.
Taken together, our findings demonstrate the unique and shared affective and cognitive components involved in decision-making among a sample of HIV+ and HIV– individuals. This is particularly important for determining who is at risk for poor decision-making and, consequently, adverse outcomes. HIV+ individuals are more likely to report higher levels of depressed mood and to demonstrate cognitive problems, making this subgroup particularly vulnerable to showing poor decision-making. Given this, understanding which mechanisms are involved in decision-making can help to identify where breakdowns in the decision-making process may occur. Clinicians working with a high-risk population, such as the HIV+ population, should be aware that despite intact cognitive functioning, dysphoric mood can interfere with the ability to make sound judgments.
References
1.
Clark L, Bechara A, Damasio H, et al.: Differential effects of insular and ventromedial prefrontal cortex lesions on risky decision-making. Brain 2008; 131:1311–1322
2.
Bechara A, Damasio H: Decision-making and addiction, part I: impaired activation of somatic states in substance dependent individuals when pondering decisions with negative future consequences. Neuropsychologia 2002; 40:1675–1689
3.
Bechara A, Damasio H, Damasio AR: Emotion, decision-making and the orbitofrontal cortex. Cereb Cortex 2000; 10:295–307
4.
Heaton RK, Grant I, Butters NHIV Neurobehavioral Research Center, et al.: The HNRC 500—neuropsychology of HIV infection at different disease stages. J Int Neuropsychol Soc 1995; 1:231–251
5.
Hardy DJ, Hinkin CH, Levine AJ, et al.: Risky decision-making assessed with the Gambling Task in adults with HIV. Neuropsychology 2006; 20:355–360
6.
Martin EM, Pitrak DL, Weddington W, et al.: Cognitive impulsivity and HIV serostatus in substance-dependent males. J Int Neuropsychol Soc 2004; 10:931–938
7.
Kalichman SC: Time to take stock in HIV/AIDS prevention. AIDS Behav 2008; 12:333–334
8.
Gonzalez R, Wardle M, Jacobus J, et al.: Influence of procedural learning on Iowa Gambling Task performance among HIV+ individuals with history of substance dependence. Arch Clin Neuropsychol 2010; 25:28–38
9.
Wardle MC, Gonzalez R, Bechara A, et al.: Iowa Gambling Task performance and emotional distress interact to predict risky sexual behavior in individuals with dual substance and HIV diagnoses. J Clin Exp Neuropsychol 2010; 32:1110–1121
10.
Castellon SA, Hinkin CH, Myers HF: Neuropsychiatric disturbance is associated with executive dysfunction in HIV-1 infection. J Int Neuropsychol Soc 2000; 6:336–347
11.
Rabkin JG, Goetz RR, Remien RH, et al.: Stability of mood despite HIV illness progression in a group of homosexual men. Am J Psychiatry 1997; 154:231–238
12.
Chamberlain SR, Sahakian BJ: The neuropsychology of mood disorders. Curr Psychiatry Rep 2006; 8:458–463
13.
Grant MM, Thase ME, Sweeney JA: Cognitive disturbance in outpatient depressed younger adults: evidence of modest impairment. Biol Psychiatry 2001; 50:35–43
14.
Kyte ZA, Goodyer IM, Sahakian BJ: Selected executive skills in adolescents with recent first-episode major depression. J Child Psychol Psychiatry 2005; 46:995–1005
15.
Hinkin CH, van Gorp WG, Satz P, et al.: Depressed mood and its relationship to neuropsychological test performance in HIV-1 seropositive individuals. J Clin Exp Neuropsychol 1992; 14:289–297
16.
Hammar A, Ardal G: Cognitive functioning in major depression: a summary. Frontiers in Human Neuroscience. 2009; 3:1–7
17.
Cella M, Dymond S, Cooper A: Impaired flexible decision-making in major depressive disorder. J Affect Disord 2010; 124:207–210
18.
Han G, Klimes-Dougan B, Jepsen S, et al.: Selective neurocognitive impairments in adolescents with major depressive disorder. J Adolesc 2011
19.
Clark L, Chamberlain SR, Sahakian BJ: Neurocognitive mechanisms in depression: implications for treatment. Annu Rev Neurosci 2009; 32:57–74
20.
Murphy FC, Sahakian BJ, Rubinsztein JS, et al.: Emotional bias and inhibitory control processes in mania and depression. Psychol Med 1999; 29:1307–1321
21.
Eshel N, Roiser JP: Reward and punishment processing in depression. Biol Psychiatry 2010; 68:118–124
22.
Forbes EE, Shaw DS, Dahl RE: Alterations in reward-related decision-making in boys with recent and future depression. Biol Psychiatry 2007; 61:633–639
23.
Henriques JB, Davidson RJ: Decreased responsiveness to reward in depression. Cogn Emotion 2000; 14:711–724
24.
McFarland BR, Klein DN: Emotional reactivity in depression: diminished responsiveness to anticipated reward but not to anticipated punishment or to nonreward or avoidance. Depress Anxiety 2009; 26:117–122
25.
Elliott R, Sahakian BJ, Herrod JJ, et al.: Abnormal response to negative feedback in unipolar depression: evidence for a diagnosis specific impairment. J Neurol Neurosurg Psychiatry 1997; 63:74–82
26.
Liu WH, Chan RCK, Wang LZ, et al.: Deficits in sustaining reward responses in subsyndromal and syndromal major depression. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35:1045–1052
27.
Murphy FC, Michael A, Robbins TW, et al.: Neuropsychological impairment in patients with major depressive disorder: the effects of feedback on task performance. Psychol Med 2003; 33:455–467
28.
Must A, Szabó Z, Bódi N, et al.: Sensitivity to reward and punishment and the prefrontal cortex in major depression. J Affect Disord 2006; 90:209–215
29.
Benjamini Y, Hochberg Y: The adaptive control of the false discovery rate in multiple comparison problems. J Educ Behav Stat 2000; 25:60–83
30.
Bechara A, Damasio AR, Damasio H, et al.: Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 1994; 50:7–15
31.
Gansler DA, Jerram MW, Vannorsdall TD, et al.: Does the Iowa Gambling Task measure executive function? Arch Clin Neuropsychol 2011; 26:706–717
32.
Cunha PJ, Bechara A, de Andrade AG, et al.: Decision-making deficits linked to real-life social dysfunction in crack cocaine-dependent individuals. Am J Addict 2011; 20:78–86
33.
Beck AT, Steer RA, Brown GK: Beck Depression Inventory Manual, 2nd Edition. San Antonio, TX, Psychological Corporation, 1996
34.
Castellon SA, Hardy DJ, Hinkin CH, et al.: Components of depression in HIV-1 infection: their differential relationship to neurocognitive performance. J Clin Exp Neuropsychol 2006; 28:420–437
35.
Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful tool to multiple testing. J Royal Stat Soc 1995; Series B, 57(1):289–300
36.
Schouten J, Cinque P, Gisslen M, et al.: HIV-1 infection and cognitive impairment in the cART era: a review. AIDS 2011; 25:561–575
37.
Jameson TL, Hinson JM, Whitney P: Components of working memory and somatic markers in decision-making. Psychon Bull Rev 2004; 11:515–520
38.
Damasio AR: The somatic marker hypothesis and the possible functions of the prefrontal cortex. Philos Trans R Soc Lond B Biol Sci 1996; 351:1413–1420
39.
Gotlib IH, Joormann J: Cognition and depression: current status and future directions. Annu Rev Clin Psychol 2010; 6:285–312
40.
Murphy FC, Rubinsztein JS, Michael A, et al.: Decision-making cognition in mania and depression. Psychol Med 2001; 31:679–693
41.
Raghunathan R, Pham MT: All negative moods are not equal: motivational influences of anxiety and sadness on decision-making. Organ Behav Hum Decis Process 1999; 79:56–77
42.
Clark LA, Watson D: Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications. J Abnorm Psychol 1991; 100:316–336
43.
Brand M, Grabenhorst F, Starcke K, et al.: Role of the amygdala in decisions under ambiguity and decisions under risk: evidence from patients with Urbach-Wiethe disease. Neuropsychologia 2007; 45:1305–1317
44.
Fellows LK, Farah MJ: Different underlying impairments in decision-making following ventromedial and dorsolateral frontal lobe damage in humans. Cereb Cortex 2005; 15:58–63
45.
Smith A: Symbol Digit Modalities Test (SDMT) Manual (Revised). Los Angeles, CA, Western Psychological Association, 1982
46.
Heaton RK, Grant I, Matthews CG: Comprehensive norms for an expanded Halstead-Reitan battery: demographic corrections, research findings, and clinical implications. Odessa, FL, Psychological Assessment Resources, 1991
47.
Delis DC, Kramer JH, Kaplan E, et al.: The California Verbal Learning Test. New York, The Psychological Corporation, 1987
48.
Stuss DT, Stethem LL, Pelchat G: Three tests of attention and rapid information-processing: an extension. The Clinical Neuropsychologist 1988; 2:246–250
49.
Wetzel L, Boll TJ: Short Category Test, Booklet Format. Los Angeles, CA, Western Psychological Services, 1987
Information & Authors
Information
Published In
History
Received: 17 November 2011
Revision received: 3 February 2012
Accepted: 27 February 2012
Published online: 1 July 2012
Published in print: Summer 2012
Authors
Funding Information
We acknowledge the following funding source: National Institute of Mental Health (NIMH) T32 MH19535 (PI: C. Hinkin).
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
View Options
View options
PDF/EPUB
View PDF/EPUBLogin options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).